Key statistics
As of last trade Novozymes A/S (NSIS B:CPH) traded at 444.10, -4.49% below its 52-week high of 465.00, set on Sep 01, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 444.30 |
|---|---|
| High | 446.90 |
| Low | 442.50 |
| Bid | 443.80 |
| Offer | 444.10 |
| Previous close | 442.50 |
| Average volume | 641.88k |
|---|---|
| Shares outstanding | 414.56m |
| Free float | 295.24m |
| P/E (TTM) | 43.81 |
| Market cap | 183.47bn DKK |
| EPS (TTM) | 10.10 DKK |
| Annual div (ADY) | 6.60 DKK |
|---|---|
| Annual div yield (ADY) | 1.49% |
| Div ex-date | Aug 25 2026 |
| Div pay-date | Aug 27 2026 |
Data delayed at least 15 minutes, as of Oct 14 2026 14:04 BST.
More ▼
- Transactions under Novonesis’ share buyback program
- Transactions under Novonesis’ share buyback program
- Novonesis completes acquisition of MicroBioGen, strengthening its yeast capabilities
- Novonesis celebrates major expansion of West Allis production facility, strengthening North American dairy innovation and manufacturing
- Transactions under Novonesis’ share buyback program
- Transactions under Novonesis’ share buyback program
- Initiation of Novonesis’ share buyback program
- Novonesis to build next generation enzyme production facility in India
- Novonesis Expands U.S. Workforce Development Efforts to Build the Next Generation of Biomanufacturing Talent
- Trading by management and close relations of management
More ▼
